Werner Lanthaler, PhD
Werner is the CEO at Evotec, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.
- Evotec, CEO
- Chief Financial Officer and Business Development and Marketing & Sales at Intercell AG in Vienna
- Contributed to gaining the product approval of Intercell’s Japanese Encephalitis vaccine and its Initial Public Offering on the Vienna Stock Exchange in 2005
- Director of the Federation of Austrian Industry and as Senior Management Consultant at McKinsey & Company
- Doctorate in Economics from Vienna University, Master’s degrees from Harvard and a degree in Psychology